Clinical Trial: Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: A Parallel Two Arm, Double Blinded Placebo Study, Examining the Efficacy of Sumatriptan With Naprosyn in the Treatment of Migraine With Aura
Brief Summary: This is a double-blinded placebo study, examining the efficacy of Sumatriptan with Naprosyn in the treatment of migraine with aura.
Detailed Summary:
Sponsor: Dent Neurologic Institute
Current Primary Outcome: Primary outcome measure will be comparative percentage of patients pain free at 2 and 4 hours from initiating treatment with placebo vs treatment with Treximet (sumatriptan with naprosyn). [ Time Frame: 2 and 4 hours ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Secondary outcomes will be percentage of patients with pain relief at 2 and 4 hours. [ Time Frame: 2 and 4 hours ]
Original Secondary Outcome: Same as current
Information By: Dent Neurologic Institute
Dates:
Date Received: May 4, 2009
Date Started: October 2010
Date Completion: December 2015
Last Updated: February 18, 2015
Last Verified: February 2015